Related Experiment Video
Updated: Aug 29, 2025
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.8K
The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures
Mario M Leitao1,2, Usha S Kreaden3, Vincent Laudone4
1Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, NY.
Annals of Surgery
|September 8, 2022
Summary
Robotic surgery shows similar long-term cancer outcomes compared to traditional methods. This systematic review found no significant differences in survival or recurrence rates across various cancer types, supporting its use.
Area of Science:
- Oncology
- Surgical Innovation
- Comparative Effectiveness Research
Background:
- Minimally invasive surgery (MIS) offers perioperative advantages over open surgery with comparable oncological results.
- Recent data on robotic surgery have raised questions regarding its long-term oncological benefits.
- Assessing long-term outcomes of robotic surgery versus laparoscopic/thoracoscopic and open surgery is crucial for guiding clinical practice.
Approach:
- A systematic review and meta-analysis adhering to PRISMA guidelines was performed.
- Searches were conducted in PubMed, Scopus, and Embase databases.
- Hazard ratios for recurrence, disease-free survival (DFS), and overall survival (OS) were extracted and pooled.
Key Points:
- For cervical cancer, OS and DFS were similar between robotic and other approaches; however, open surgery showed less recurrence.
- Robotic surgery favored endometrial cancer OS over open surgery.
- Lobectomy showed improved DFS with robotic vs. thoracoscopic and improved OS with robotic vs. open surgery.
- Prostatectomy and low-anterior resection demonstrated better recurrence and OS outcomes with robotic surgery compared to laparoscopic and open approaches.
Conclusions:
- Long-term oncological outcomes for robotic surgery are comparable to laparoscopic/thoracoscopic and open surgery across multiple cancer types.
- No significant safety signals or indications for further research were identified.
- The findings support the continued use of robotic surgery in various oncological procedures.
